SKP2 and neoplasm: Hinokitiol has also been shown to inhibit tumor cell proliferation, in part, by G1 cell cycle arrest characterized by downregulated pRb and Skp2 ubiquitin ligase, and an impaired Cdk2 kinase activity 25.